兽药企业财务分析(PPT 88页)

主要内容
Alpharma: New Platform for Growth
Welcome
Forward Looking Statement
Webcast Information and Presentation Assumptions
Agenda
Company Overview
Specialty Pharmaceutical Businesses
Growth Strategy
Growth Potential
Financial Overview
ALO Financial History
Cash Available for Investment
2006 OutlookFull Year 2006 EPS $1.25 - $1.35
Animal Health
What We’ll Talk About
Animal Health Market
Animal Health Performance
Intestinal (Enteric) Product Offering
Respiratory Product Offerings
Today
Growing the Business
Expanding Share in Current Business
New Products
# of Planned AH New Product Launches
Product Launch Calendar
Potential New Product Revenues
Summary
Active Pharmaceutical Ingredients
API Overview
API Performance
Strategy
Expand Our Successful Current Business
ummary – Significant Growth Opportunities
Branded Pharmaceuticals
Business Overview
Market Overview
KADIAN® Financial Performance
KADIAN® Prescription (TRx) Performance - 2005
KADIAN® Prescription (TRx) Performance – 2005-2006
KADIAN® Market Share – 2005
Comparison of Long-acting Opioids
Intellectual Property
Growing the Business – How?
Wrap Up

..............................